Who Makes This Medication?
Daliresp is made by Nycomed GmbH for Forest Pharmaceuticals, Inc.
Daliresp inhibits an enzyme called phosphodiesterase type-4 (PDE4). By inhibiting PDE4, Daliresp increases the level of cyclic adenosine monophosphate (cAMP) in cells. It is not entirely clear how this action helps with COPD treatment, although it is thought that anti-inflammatory actions may be involved.
Clinical studies have shown that Daliresp reduces the risk of moderate or severe COPD
exacerbations by 15 to 18 percent, compared to treatment with a placebo (a "sugar pill" that does not contain any active ingredients).
Some general considerations to keep in mind during treatment with this medication include the following:
- Daliresp comes in tablet form. It is usually taken by mouth once a day.
- Try to take your dose at the same time each day to keep an even level in your blood.
- You can take this medication with or without food.
- For this medicine to work properly, it must be taken as prescribed.